Lacosamide Ucb

Lacosamide, the active ingredient in Lacosamide Ucb, is a anti‑epileptic presented as a injection for intravenous use. It treats partial‑onset seizures in patients with epilepsy.

GNH USA supplies Lacosamide Ucb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an anticonvulsant used in the management of seizure disorders.

Partial‑onset seizures: reduces seizure frequency as adjunctive therapy in epilepsy patients. Epilepsy: provides additional seizure control when monotherapy is insufficient. Focal seizures: improves overall seizure management as part of a combination regimen.

Lacosamide may cause a range of adverse reactions, some of which are more frequent than others.

Common Side Effects: - Dizziness - Nausea - Headache - Fatigue

Serious or Rare Side Effects: - Cardiac arrhythmia, including atrioventricular block - Severe skin reactions such as Stevens‑Johnson syndrome - Hypersensitivity reactions that may require immediate medical attention

When using Lacosamide injection, several safety considerations should be observed.

Renal impairment: monitor dosing and plasma levels. Hepatic impairment: use with caution and consider dose adjustment. Concomitant cardiac drugs: observe ECG for conduction changes. Pregnancy: prescribe only if potential benefit justifies the risk. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lacosamide can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Class I antiarrhythmics: may exacerbate cardiac conduction abnormalities. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase lacosamide plasma concentrations. - Strong CYP3A4 inducers (e.g., rifampin): may lower lacosamide effectiveness.

Moderate Interactions (Monitor Closely): - Carbamazepine: may increase risk of dizziness and somnolence. - Phenytoin: may alter lacosamide plasma levels. - Alcohol: may enhance central nervous system depression.